SE435380B - Forfarande for framstellning av kinazolinforeningar - Google Patents

Forfarande for framstellning av kinazolinforeningar

Info

Publication number
SE435380B
SE435380B SE7705745A SE7705745A SE435380B SE 435380 B SE435380 B SE 435380B SE 7705745 A SE7705745 A SE 7705745A SE 7705745 A SE7705745 A SE 7705745A SE 435380 B SE435380 B SE 435380B
Authority
SE
Sweden
Prior art keywords
chinazoline
compounds
procedure
preparation
chinazoline compounds
Prior art date
Application number
SE7705745A
Other languages
English (en)
Swedish (sv)
Other versions
SE7705745L (sv
Inventor
P D Hammen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7705745L publication Critical patent/SE7705745L/xx
Publication of SE435380B publication Critical patent/SE435380B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7705745A 1976-06-15 1977-05-16 Forfarande for framstellning av kinazolinforeningar SE435380B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69620176A 1976-06-15 1976-06-15

Publications (2)

Publication Number Publication Date
SE7705745L SE7705745L (sv) 1977-12-16
SE435380B true SE435380B (sv) 1984-09-24

Family

ID=24796111

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7705745A SE435380B (sv) 1976-06-15 1977-05-16 Forfarande for framstellning av kinazolinforeningar
SE8107554A SE450120B (sv) 1976-06-15 1981-12-16 Nya dimetoxikinazolinderivat till anvendning for framstellning av 2(4-substituerade piperazin-1-yl)-4-amino-6,7-dimetoxikinazoliner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8107554A SE450120B (sv) 1976-06-15 1981-12-16 Nya dimetoxikinazolinderivat till anvendning for framstellning av 2(4-substituerade piperazin-1-yl)-4-amino-6,7-dimetoxikinazoliner

Country Status (34)

Country Link
JP (1) JPS52153985A (fi)
AR (1) AR218251A1 (fi)
AT (1) AT356115B (fi)
BE (1) BE855656A (fi)
BG (3) BG35594A3 (fi)
CA (1) CA1068698A (fi)
CH (3) CH638203A5 (fi)
CS (1) CS202069B2 (fi)
DD (1) DD131021A5 (fi)
DE (1) DE2725019A1 (fi)
DK (1) DK146625C (fi)
EG (1) EG12922A (fi)
ES (1) ES459364A1 (fi)
FI (1) FI66853C (fi)
FR (1) FR2355015A1 (fi)
GB (1) GB1548856A (fi)
GR (1) GR72288B (fi)
HK (1) HK31481A (fi)
HU (1) HU177883B (fi)
IE (1) IE45423B1 (fi)
IL (1) IL52167A (fi)
LU (1) LU77530A1 (fi)
MY (1) MY8100270A (fi)
NL (1) NL172543C (fi)
NO (1) NO147838C (fi)
NZ (1) NZ184168A (fi)
PH (1) PH22196A (fi)
PL (3) PL105558B1 (fi)
PT (1) PT66617B (fi)
RO (3) RO77308A (fi)
SE (2) SE435380B (fi)
SU (2) SU1033002A3 (fi)
YU (1) YU40164B (fi)
ZA (1) ZA773014B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346675A1 (de) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5679683A (en) * 1994-01-25 1997-10-21 Warner-Lambert Company Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3669968A (en) 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
JPS4966691A (fi) * 1972-10-30 1974-06-27
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
JPS50126682A (fi) * 1974-03-25 1975-10-04

Also Published As

Publication number Publication date
SE450120B (sv) 1987-06-09
PT66617A (en) 1977-06-01
PL198874A1 (pl) 1978-04-10
FR2355015A1 (fr) 1978-01-13
PL111221B1 (en) 1980-08-30
ATA386977A (de) 1979-09-15
BG35594A3 (en) 1984-05-15
NL172543B (nl) 1983-04-18
CH638516A5 (en) 1983-09-30
RO77330A (ro) 1981-06-22
SU946402A3 (ru) 1982-07-23
NL7705939A (nl) 1977-12-19
YU40164B (en) 1985-08-31
FI66853B (fi) 1984-08-31
PT66617B (en) 1978-10-27
PH22196A (en) 1988-06-28
BG35748A3 (en) 1984-06-15
BE855656A (fr) 1977-12-14
JPS52153985A (en) 1977-12-21
FI771741A (fi) 1977-12-16
DE2725019A1 (de) 1977-12-22
ZA773014B (en) 1978-04-26
IE45423L (en) 1977-12-15
MY8100270A (en) 1981-12-31
NL172543C (nl) 1983-09-16
NZ184168A (en) 1979-08-31
BG35747A3 (en) 1984-06-15
PL105558B1 (pl) 1979-10-31
IE45423B1 (en) 1982-08-25
SU1033002A3 (ru) 1983-07-30
AU2558377A (en) 1978-09-07
DK146625B (da) 1983-11-21
SE8107554L (sv) 1981-12-16
LU77530A1 (fr) 1979-03-26
FI66853C (fi) 1984-12-10
GR72288B (fi) 1983-10-17
SE7705745L (sv) 1977-12-16
CH638517A5 (en) 1983-09-30
AT356115B (de) 1980-04-10
FR2355015B1 (fi) 1981-07-24
CA1068698A (en) 1979-12-25
HU177883B (en) 1982-01-28
NO771919L (no) 1977-12-16
DD131021A5 (de) 1978-05-24
YU132677A (en) 1982-08-31
DK146625C (da) 1984-06-04
PL113012B1 (en) 1980-11-29
NO147838B (no) 1983-03-14
NO147838C (no) 1983-06-22
RO77308A (ro) 1981-08-17
EG12922A (en) 1980-03-31
IL52167A (en) 1981-01-30
CS202069B2 (en) 1980-12-31
AR218251A1 (es) 1980-05-30
RO73050A (ro) 1981-08-30
GB1548856A (en) 1979-07-18
IL52167A0 (en) 1977-07-31
DK240877A (da) 1977-12-16
JPS5543465B2 (fi) 1980-11-06
HK31481A (en) 1981-07-10
ES459364A1 (es) 1978-03-16
CH638203A5 (en) 1983-09-15

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
NO774147L (no) Fremgangsmaate for fremstilling av kinazolinonforbindelser

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7705745-3

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7705745-3

Format of ref document f/p: F